C-reactive protein and fatigue after subarachnoid haemorrhage
C-reactive protein and fatigue after subarachnoid haemorrhage
Background: Subarachnoid haemorrhage (SAH) is a severe type of intracranial bleed that causes significant morbidity. One of the most overlooked yet commonly reported symptom is persistent fatigue. Fatigue in the general population has been associated with inflammation and elevated C-reactive protein (CRP). Since inflammation and raised CRP are observed post-SAH, we hypothesized that CRP is associated with fatigue severity after SAH.
Methods: Data from 95 patients (26 males, 69 females; mean age 56 years) previously recruited to the SAS trial, a prospective randomised controlled trial (2016-2019) investigating the efficacy of sulforaphane after SAH, were analyzed. In this study CRP was measured on days 1, 7, and 28 post-SAH, and fatigue severity assessed using the Short-Form Health Survey (SF-36) on days 28, 90, and 180. Multivariable regression was conducted controlling for confounders, including age, gender, initial volume of blood on CT and World Federation of Neurological Surgeons (WFNS) grade.
Results: There was a robust association between the severity of fatigue at day 28 and CRP levels at baseline (OR = -2.67 (-1.23 to -0.18), p = 0.001) and CRP on day 28 (OR = -2.56 (-1.01 to -0.12), p = 0.013), even after controlling for confounders including blood volume and WFNS. There was no suggestion of an association between day 7 CRP and fatigue on day 28 (OR = -1.07 (-0.82 to 0.25), p = 0.287). There were no associations with any other fatigue timepoints.
Conclusion: CRP and fatigue in SAH patients are associated. The timings of the associations of baseline and day 28 CRP (but not day 7) with day 28 fatigue, and their independence from bleed severity suggest that fatigue is related partly to the magnitude of the initial response to the SAH and partly due to the degree of ongoing response at day 28 but not due to other events occurring in between. The lack of association of early CRP with fatigue beyond day 28 suggests that later fatigue is not driven by the initial CRP-related response to SAH. Further studies are needed to examine later CRP and the determinants of persistent fatigue.
Daniel, Sean
57a864af-6606-49bb-a9e9-97e323623900
Hou, Ruihua
470bdcbc-93a9-4dad-aac5-26d455c34376
Galea, Ian
66209a2f-f7e6-4d63-afe4-e9299f156f0b
Bulters, Diederik
12e3bdfb-52e9-4154-9d41-925839afff8d
24 July 2025
Daniel, Sean
57a864af-6606-49bb-a9e9-97e323623900
Hou, Ruihua
470bdcbc-93a9-4dad-aac5-26d455c34376
Galea, Ian
66209a2f-f7e6-4d63-afe4-e9299f156f0b
Bulters, Diederik
12e3bdfb-52e9-4154-9d41-925839afff8d
Daniel, Sean, Hou, Ruihua, Galea, Ian and Bulters, Diederik
(2025)
C-reactive protein and fatigue after subarachnoid haemorrhage.
Brain, Behavior, & Immunity - Health, 48 (101046), [101046].
(doi:10.1016/j.bbih.2025.101046).
Abstract
Background: Subarachnoid haemorrhage (SAH) is a severe type of intracranial bleed that causes significant morbidity. One of the most overlooked yet commonly reported symptom is persistent fatigue. Fatigue in the general population has been associated with inflammation and elevated C-reactive protein (CRP). Since inflammation and raised CRP are observed post-SAH, we hypothesized that CRP is associated with fatigue severity after SAH.
Methods: Data from 95 patients (26 males, 69 females; mean age 56 years) previously recruited to the SAS trial, a prospective randomised controlled trial (2016-2019) investigating the efficacy of sulforaphane after SAH, were analyzed. In this study CRP was measured on days 1, 7, and 28 post-SAH, and fatigue severity assessed using the Short-Form Health Survey (SF-36) on days 28, 90, and 180. Multivariable regression was conducted controlling for confounders, including age, gender, initial volume of blood on CT and World Federation of Neurological Surgeons (WFNS) grade.
Results: There was a robust association between the severity of fatigue at day 28 and CRP levels at baseline (OR = -2.67 (-1.23 to -0.18), p = 0.001) and CRP on day 28 (OR = -2.56 (-1.01 to -0.12), p = 0.013), even after controlling for confounders including blood volume and WFNS. There was no suggestion of an association between day 7 CRP and fatigue on day 28 (OR = -1.07 (-0.82 to 0.25), p = 0.287). There were no associations with any other fatigue timepoints.
Conclusion: CRP and fatigue in SAH patients are associated. The timings of the associations of baseline and day 28 CRP (but not day 7) with day 28 fatigue, and their independence from bleed severity suggest that fatigue is related partly to the magnitude of the initial response to the SAH and partly due to the degree of ongoing response at day 28 but not due to other events occurring in between. The lack of association of early CRP with fatigue beyond day 28 suggests that later fatigue is not driven by the initial CRP-related response to SAH. Further studies are needed to examine later CRP and the determinants of persistent fatigue.
Text
1-s2.0-S2666354625001048-main
- Version of Record
More information
Accepted/In Press date: 26 June 2025
e-pub ahead of print date: 30 June 2025
Published date: 24 July 2025
Identifiers
Local EPrints ID: 505974
URI: http://eprints.soton.ac.uk/id/eprint/505974
ISSN: 2666-3546
PURE UUID: 4399c733-e29d-4dc0-a596-5fd3ec802360
Catalogue record
Date deposited: 24 Oct 2025 16:48
Last modified: 05 Dec 2025 02:40
Export record
Altmetrics
Contributors
Author:
Sean Daniel
Author:
Diederik Bulters
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics